Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Bjune

Showing results (71-80 of 96) with videos related to

Pageof 10
Sort By:
International Journal of Leprosy and Other Mycobacterial Diseases : Official Organ of the International Leprosy Association|December 1, 1982
Pregnancy and leprosy: the consequences of alterations of cell-mediated and humoral immunity during pregnancy and lactationM E Duncan, J M Pearson, D S Ridley, et al.
Microbial Pathogenesis|December 1, 1994
Comparison of the class-1 outer membrane protein from B:15:P1.16 Neisseria meningitidis strains isolated from patients previously immunized with a serogroup B outer membrane protein vaccine in NorwayJ L Brooks, E Rosenqvist, G Bjune, et al.
APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica|August 1, 1991
Immunization against serogroup B meningococci. Opsonin response in vaccinees as measured by chemiluminescenceA K Lehmann, A Halstensen, A Naess, et al.
NIPH Annals|December 1, 1991
Design of clinical trials with an outer membrane vesicle vaccine against systemic serogroup B meningococcal disease in NorwayG Bjune, O Closs, L O Frøholm, et al.
NIPH Annals|December 1, 1991
Serum opsonins to serogroup B meningococci after disease and vaccinationA Halstensen, A K Lehmann, H K Guttormsen, et al.
Infection and Immunity|September 1, 1995
Comparison among opsonic activity, antimeningococcal immunoglobulin G response, and serum bactericidal activity against meningococci in sera from vaccinees after immunization with a serogroup B outer membrane vesicle vaccineA Aase, G Bjune, E A Høiby, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|January 22, 2004
Impact of drug-resistant Mycobacterium tuberculosis on treatment outcome of culture-positive cases of tuberculosis in the Archangel oblast, Russia, in 1999O S Toungoussova, N I Nizovtseva, A O Mariandyshev, et al.
NIPH Annals|December 1, 1991
Bactericidal antibodies after vaccination with the Norwegian meningococcal serogroup B outer membrane vesicle vaccine: a brief surveyE A Høiby, E Rosenqvist, L O Frøholm, et al.
Transactions of the Royal Society of Tropical Medicine and Hygiene|August 16, 2005
Risk factors associated with typhoid fever in Son La province, northern VietnamH H Tran, G Bjune, B M Nguyen, et al.
Vaccine|August 1, 1997
Outer membrane vesicle vaccines made from short-chain lipopolysaccharide mutants of serogroup B Neisseria meningitidis: effect of the carbohydrate chain length on the immune responseS R Andersen, G Bjune, E A Høiby, et al.
Pageof 10

Showing results (71-80 of 96) with videos related to

Sort By:
Pageof 10
International Journal of Leprosy and Other Mycobacterial Diseases : Official Organ of the International Leprosy Association|December 1, 1982
Pregnancy and leprosy: the consequences of alterations of cell-mediated and humoral immunity during pregnancy and lactationM E Duncan, J M Pearson, D S Ridley, et al.
Microbial Pathogenesis|December 1, 1994
Comparison of the class-1 outer membrane protein from B:15:P1.16 Neisseria meningitidis strains isolated from patients previously immunized with a serogroup B outer membrane protein vaccine in NorwayJ L Brooks, E Rosenqvist, G Bjune, et al.
APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica|August 1, 1991
Immunization against serogroup B meningococci. Opsonin response in vaccinees as measured by chemiluminescenceA K Lehmann, A Halstensen, A Naess, et al.
NIPH Annals|December 1, 1991
Design of clinical trials with an outer membrane vesicle vaccine against systemic serogroup B meningococcal disease in NorwayG Bjune, O Closs, L O Frøholm, et al.
NIPH Annals|December 1, 1991
Serum opsonins to serogroup B meningococci after disease and vaccinationA Halstensen, A K Lehmann, H K Guttormsen, et al.
Infection and Immunity|September 1, 1995
Comparison among opsonic activity, antimeningococcal immunoglobulin G response, and serum bactericidal activity against meningococci in sera from vaccinees after immunization with a serogroup B outer membrane vesicle vaccineA Aase, G Bjune, E A Høiby, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|January 22, 2004
Impact of drug-resistant Mycobacterium tuberculosis on treatment outcome of culture-positive cases of tuberculosis in the Archangel oblast, Russia, in 1999O S Toungoussova, N I Nizovtseva, A O Mariandyshev, et al.
NIPH Annals|December 1, 1991
Bactericidal antibodies after vaccination with the Norwegian meningococcal serogroup B outer membrane vesicle vaccine: a brief surveyE A Høiby, E Rosenqvist, L O Frøholm, et al.
Transactions of the Royal Society of Tropical Medicine and Hygiene|August 16, 2005
Risk factors associated with typhoid fever in Son La province, northern VietnamH H Tran, G Bjune, B M Nguyen, et al.
Vaccine|August 1, 1997
Outer membrane vesicle vaccines made from short-chain lipopolysaccharide mutants of serogroup B Neisseria meningitidis: effect of the carbohydrate chain length on the immune responseS R Andersen, G Bjune, E A Høiby, et al.
Pageof 10